About Sterling Pharma Solutions
Sterling Pharma Solutions is a company based in Dudley (United Kingdom) founded in 2016 was acquired by GHO Capital Partners in February 2019. Sterling Pharma Solutions has completed 3 acquisitions, including ADC Biotechnology, CiVentiChem and NewChem Technologies. Sterling Pharma Solutions offers products and services including API Development, API Manufacturing, ADC Development, Peptide Manufacturing, and Analytical Services. Sterling Pharma Solutions operates in a competitive market with competitors including Laurus Labs, Provepharm Life Solutions, Symbiotec, Jubilant Pharma and SeQuent, among others.
- Headquarter Dudley, United Kingdom
-
Sectors
Healthcare
-
Phone
Locked
-
Website
Locked
-
Social
Locked
- Legal Name Sterling Pharma Solutions Limited
- Date of Incorporation 16 Feb, 2006
- Jurisdiction NORTHUMBERLAND
-
Annual Revenue
Not available
-
Net Profit
Not available
-
EBITDA
Not available
-
Latest Funding Round
Not available
-
Investors
Partners Group
& 1 more
-
Employee Count
Not available
-
Investments & Acquisitions
ADC Biotechnology
& 2 more
-
Acquired by
GHO Capital Partners
(Feb 28, 2019)
Unlock complete access to The Company Check
Get unrestricted viewing across everything we track — from companies and brands to investors, funding rounds, acquisitions, financials, and more.
- Unlimited viewing on all profiles Companies, investors, financials, funding, acquisitions & directors
- Full access to every database India & global coverage, advanced filters and rich profile details
- Always-on access from your team account Single premium plan for everything you see on the portal
Products & Services of Sterling Pharma Solutions
Sterling Pharma Solutions offers a comprehensive portfolio of products and services, including API Development, API Manufacturing, ADC Development, Peptide Manufacturing, and Analytical Services.
Services for API route scouting and process optimization.
cGMP production of APIs including high-potency and hazardous compounds.
Support for ADC discovery, development, and clinical manufacturing.
Analysis, purification, and production of novel peptides.
Techniques like mass spectrometry for drug molecule evaluation.
People of Sterling Pharma Solutions
Unlock access to complete
Software Development Team
44 people
Product Management Team
22 people
Leadership Team
16 people
Senior Team
15 people
Human Resources and Administration
13 people
Sales and Marketing
12 people
Process Team
8 people
Principal Team
5 people
Unlock access to complete
Funding Insights of Sterling Pharma Solutions
Investors in Sterling Pharma Solutions
Sterling Pharma Solutions has secured backing from 2 investors, including venture fund investors. Prominent investors backing the company include Partners Group and GHO Capital.
| Investor | Description | Founded Year | Domain | Location |
|---|---|---|---|---|
|
Specialist healthcare investment advisory services are provided by GHO Capital.
|
Locked | Locked | Locked | |
|
Private equity funds are managed across multiple sectors globally.
|
Locked | Locked | Locked |
Investor details for Sterling Pharma Solutions
Investor domains, locations, round participation, and complete history require an active premium plan.
- Investor domains
- Investor locations
- Funding rounds
- Participation history
Verified entity values are shown only after access is granted.
Investments & Acquisitions by Sterling Pharma Solutions
Sterling Pharma Solutions has strategically engaged in corporate development activities, having acquired 3 companies. Notable acquisitions include ADC Biotechnology, CiVentiChem and NewChem Technologies.
Investment portfolio details for Sterling Pharma Solutions
Portfolio company identities, transaction dates, round details, and investment values require an active premium plan.
- Portfolio identities
- Transaction dates
- Round details
- Investment values
Verified entity values are shown only after access is granted.
| Company Name | Description | Domain | Location | Founded Year | Amount |
|---|---|---|---|---|---|
|
Developer of antibody drug conjugate (ADC)
|
Locked | Locked | 2010 | Locked | |
|
NewChem Technologies is an chemical company specializing in commercial applications for organic chemistry.
|
Locked | Locked | 2002 | Locked | |
|
Contract research and manufacturing services are offered for pharmaceuticals.
|
Locked | Locked | 1994 | Locked |
Complete acquisition details for Sterling Pharma Solutions
Transaction dates, acquired stakes, disclosed values, domains, and locations require an active premium plan.
- Transaction dates
- Acquired stakes
- Disclosed values
- Domains and locations
Verified entity values are shown only after access is granted.
Financial Statements - Sterling Pharma Solutions
Detailed financials for Sterling Pharma Solutions
Historical revenue, profit, statement rows, ratios, and trend charts require an active premium plan.
- Historical revenue
- Profit trends
- Statement rows
- Financial ratios
Verified entity values are shown only after access is granted.
Sterling Pharma Solutions Comparisons
Peer comparison for Sterling Pharma Solutions
Named peer metrics, headcount, funding, location, and side-by-side benchmarks require an active premium plan.
- Named peers
- Headcount comparison
- Funding comparison
- Operating benchmarks
Verified entity values are shown only after access is granted.
Competitors of Sterling Pharma Solutions
Sterling Pharma Solutions operates in a dynamic and competitive business environment, facing competition from various established players and emerging companies in the market. The competitive landscape includes prominent companies such as Laurus Labs, Provepharm Life Solutions, Symbiotec, Jubilant Pharma and SeQuent, among others.
| Company Name | Domain | Founded year | HQ Location | Description |
|---|---|---|---|---|
| Locked | Locked | Locked |
Pharmaceutical and biotechnology company
|
|
| Locked | Locked | Locked |
APIs and drug products are developed and valorized in pharmaceuticals.
|
|
| Locked | Locked | Locked |
Non-sterile steroid hormone-based APIs and intermediates are manufactured.
|
|
| Locked | Locked | Locked |
Pharmaceuticals, APIs, and radiopharmaceuticals are manufactured by the company.
|
|
| Locked | Locked | Locked |
APIs are developed and manufactured for therapeutic areas.
|
Detailed competitors of Sterling Pharma Solutions
Competitor domains, locations, full profiles, and operating metrics require an active premium plan.
- Domains and locations
- Full company profiles
- Operating metrics
- Competitive positioning
Verified entity values are shown only after access is granted.
Latest news on Sterling Pharma Solutions
Complete news archive for Sterling Pharma Solutions
Full article history, source details, and older brand coverage require an active premium plan.
- Full article archive
- Source and publication date
- Older coverage
- Brand-specific news history
Verified entity values are shown only after access is granted.
Frequently Asked Questions about Sterling Pharma Solutions
Sterling Pharma Solutions was founded in 2016 and raised its 1st funding round 7 years after it was founded.
Sterling Pharma Solutions is headquartered in Dudley, United Kingdom. It is registered at Dudley, West Midlands, United Kingdom.
Kevin Cook is the current CEO of Sterling Pharma Solutions.
Sterling Pharma Solutions was established in 2016 in Dudley, United Kingdom. Operations focus on the pharmaceutical sector as a contract development and manufacturing organization (CDMO). Services encompass contract development, manufacturing, and analytical support specifically for active pharmaceutical ingredients (APIs). The company is led by CEO Kevin Cook and maintains its primary location in the UK to serve global clients in the industry.
Sterling Pharma Solutions's top competitors include Laurus Labs, Symbiotec and Provepharm Life Solutions.
Sterling Pharma Solutions offers API Development, API Manufacturing, ADC Development, Peptide Manufacturing, and Analytical Services.
Sterling Pharma Solutions has made 3 acquisitions, including ADC Biotechnology, CiVentiChem, and NewChem Technologies.
Sterling Pharma Solutions has 2 investors. Key investors include Partners Group, and GHO Capital.